Big Pharma Sharma
@bigpharmasharma.com
Drug Strategist. Delivering industry insider insights
Newsletter➡️: http://bigpharmasharma.com
Podcast➡️: https://youtube.com/@DrugDealinPod
Newsletter➡️: http://bigpharmasharma.com
Podcast➡️: https://youtube.com/@DrugDealinPod
NEW EPISODE of our podcast, Drug Dealin'
We predict 2026 in biopharma: M&A heating up, FDA shifts, psychedelics breakthrough year, DTC rising & branded drugs slipstreaming GLP-1 success.
Watch highlight clip + full episode links in the first comment
We predict 2026 in biopharma: M&A heating up, FDA shifts, psychedelics breakthrough year, DTC rising & branded drugs slipstreaming GLP-1 success.
Watch highlight clip + full episode links in the first comment
January 31, 2026 at 12:33 AM
NEW EPISODE of our podcast, Drug Dealin'
We predict 2026 in biopharma: M&A heating up, FDA shifts, psychedelics breakthrough year, DTC rising & branded drugs slipstreaming GLP-1 success.
Watch highlight clip + full episode links in the first comment
We predict 2026 in biopharma: M&A heating up, FDA shifts, psychedelics breakthrough year, DTC rising & branded drugs slipstreaming GLP-1 success.
Watch highlight clip + full episode links in the first comment
Episode 4 of my podcast, Drug Dealin, is now live. You can watch/listen at bigpharmasharma.com or by subscribing to Drug Dealin on your podcast platform of choice.
In #4 we take dive into oral GLP-1s and GLP-1s are moving into brain diseases
Looking forward to hearing your feedback on this one!
In #4 we take dive into oral GLP-1s and GLP-1s are moving into brain diseases
Looking forward to hearing your feedback on this one!
May 19, 2025 at 5:40 PM
Episode 4 of my podcast, Drug Dealin, is now live. You can watch/listen at bigpharmasharma.com or by subscribing to Drug Dealin on your podcast platform of choice.
In #4 we take dive into oral GLP-1s and GLP-1s are moving into brain diseases
Looking forward to hearing your feedback on this one!
In #4 we take dive into oral GLP-1s and GLP-1s are moving into brain diseases
Looking forward to hearing your feedback on this one!
Episode 3 of my BioPharma podcast, Drug Dealin', is live. We spoke to Sujal Shah, CEO of CymaBay about the company's ups & downs with seladelpar and resilience leading a company through adversity.
Tap-in wherever you get your podcasts: youtu.be/TixS06gbfQc?...
open.spotify.com/episode/1tct...
Tap-in wherever you get your podcasts: youtu.be/TixS06gbfQc?...
open.spotify.com/episode/1tct...
March 10, 2025 at 5:01 PM
Episode 3 of my BioPharma podcast, Drug Dealin', is live. We spoke to Sujal Shah, CEO of CymaBay about the company's ups & downs with seladelpar and resilience leading a company through adversity.
Tap-in wherever you get your podcasts: youtu.be/TixS06gbfQc?...
open.spotify.com/episode/1tct...
Tap-in wherever you get your podcasts: youtu.be/TixS06gbfQc?...
open.spotify.com/episode/1tct...